ClinicalTrials.Veeva

Menu
S

Schuster Medical Research Institute | Sherman Oaks, CA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

SEP-363856
KarXT
Cariprazine
Bapineuzumab
Atogepant
BMS-820836
Lasmiditan
MK-8189
Aripiprazole
Leuco-methylthioninium Bis(Hydromethanesulfonate)

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 37 total trials

A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia

Evaluate the efficacy and safety of Ulotaront (SEP-363856) in acutely psychotic subjects with schizophrenia

Enrolling
Schizophrenia
Drug: SEP-363856
Other: Placebo

Trial sponsors

Otsuka logo
AbbVie logo
Janssen (J&J Innovative Medicine) logo
Karuna Therapeutics logo
Lilly logo
Allergan logo
Bristol-Myers Squibb (BMS) logo
Merck Sharp & Dohme (MSD) logo
T
Acadia Pharmaceuticals logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems